Lieber Institute for Brain Development
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Lieber Institute for Brain Development
The family-owned German pharma dates back to 1885 and tries to keep up with its publicly traded peers by not mimicking everything they do, but with a “value by innovation” focus.
Taysha gains control of GAN candidate and program; BI licenses COMT inhibitors from Lieber Institute; plus three new gene therapy-driven tie-ups between biopharma and academia.
- Academic and Research Institutions
- Other Names / Subsidiaries
- Lieber Institute for Brain Development Maltz Research Laboratories (LIBD/MRL)
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.